TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
28/04/2025
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Fundamento do pedido
Código do desenho
Tipo de titular
Localização do titular
Examinador
Localização atual
Descrição da marca
The mark consists of an abstract design in the color light blue, within which is a white upside down letter T on top of a white right side up letter T.
Titulares
Representantes
Stacy J. Grossman SGIP
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for protection from and prevention of viral and bacterial infections, cancer, inflammation, infectious diseases and non-infectious diseases, namely, musculoskeletal, cardiovascular, cardiopulmonary, oncological, neurological, dermatological, genitourinary, sexual dysfunction, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, psychiatric and immune system diseases and disorders; chemical and biological pharmaceutical preparations for medical purposes, namely, for protection from and prevention of viral and bacterial infections, cancer, inflammation, infectious diseases and non-infectious diseases, namely, musculoskeletal, cardiovascular, cardiopulmonary, oncological, neurological, dermatological, genitourinary, sexual dysfunction, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, psychiatric and immune system diseases and disorders; chemical preparations for use in DNA analysis for medical purposes; DNA synthesis inhibitors for medical purposes, namely, pharmaceutical preparations for protection from and prevention of viral and bacterial infections, cancer, inflammation, infectious diseases and non-infectious diseases, namely, musculoskeletal, cardiovascular, cardiopulmonary, oncological, neurological, dermatological, genitourinary, sexual dysfunction, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, psychiatric and immune system diseases and disorders; biological preparations for the treatment of cancer; biological preparations for the treatment of viral and bacterial infections; biological preparations for the treatment of autoimmune diseases; biological preparations for medical use for the treatment of viral and bacterial infections, cancer, inflammation, infectious diseases and non-infectious diseases, namely, musculoskeletal, cardiovascular, cardiopulmonary, oncological, neurological, dermatological, genitourinary, sexual dysfunction, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, psychiatric and immune system diseases and disorders; immunotherapeutic drugs namely, pharmaceutical preparations for protection from and prevention of viral and bacterial infections, cancer, inflammation, infectious diseases and non-infectious diseases, namely, musculoskeletal, cardiovascular, cardiopulmonary, oncological, neurological, dermatological, genitourinary, sexual dysfunction, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, psychiatric and immune system diseases and disorders; reagents for medical use; diagnostic preparations for medical use; diagnostic reagents for medical use; preparations for detecting genetic predispositions for medical purposes
Classe 9
Downloadable computer software for use in collecting, analyzing and organizing data in the field of pharmaceuticals, biopharmaceutical drug development and genome engineering; downloadable computer software for use in collecting, analyzing and organizing data in the field of scientific and pharmaceutical research and development; downloadable software for scientific modelling of pharmaceuticals in the field of scientific and pharmaceutical research and development; downloadable software for pharmaceutical modelling; downloadable software for research and development in the nature of collecting, analyzing and organizing data in the field of antibodies; devices for analyzing genome information, namely, laboratory devices for detecting genetic sequences; downloadable software for performing gene sequencing research and visualization, namely, scientific analysis of genetic sequences; downloadable software for the managing, analysis, and visualization of biological data
Classe 42
Scientific and technological services, namely, scientific research and development in the field of pharmaceuticals for genome engineering and biopharmaceutical drug development for protection from infections, cancer, disease or inflammation; technical research in the field of pharmaceutical studies; design and development of computer hardware and software; platform as a service (PAAS) featuring computer software platforms for use in database management in the field of pharmaceuticals, biopharmaceutical drug development and genome engineering; platform as a service (PAAS) featuring DNA analysis software platforms; software as a service (SAAS) services featuring software for use in database management in the field of pharmaceuticals, biopharmaceutical drug development and genome engineering; software as a service (SAAS) services featuring DNA analysis software; provision of online non-downloadable software for the management, visualization and analysis of biological data for the purposes of biomolecular research and the design and engineering of biomolecular products; DNA analysis services in the field of DNA sequencing for scientific research; provision of a web hosting platform for the analysis of DNA sequencing data for scientific research purposes and diagnostic and treatment purposes
Classe 44
Medical services; diagnostic and prognostic medical services; veterinary services; medical analysis services relating to the treatment of persons; pharmaceutical advice; medical and health care services relating to DNA, genetics, and genetic pathogen testing for diagnostic or treatment purposes; medical screening and assaying in the nature of medical laboratory analysis services relating to the treatment of persons; DNA screening for medical purposes; DNA analysis services in the field of DNA sequencing for diagnostic and treatment purposes provided by medical laboratories
Histórico de despachos e eventos da marca no USPTO.
41 publicações encontradas
TEAS CHANGE OF CORRESPONDENCE RECEIVED
28/04/2025
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
28/04/2025
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
28/04/2025
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
28/04/2025
TEAS CHANGE OF OWNER ADDRESS RECEIVED
28/04/2025
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/03/2025
REGISTERED-PRINCIPAL REGISTER
11/03/2025
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
21/01/2025
PUBLISHED FOR OPPOSITION
21/01/2025
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
15/01/2025
APPROVED FOR PUB - PRINCIPAL REGISTER
27/12/2024
EXAMINER'S AMENDMENT ENTERED
27/12/2024
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
27/12/2024
EXAMINERS AMENDMENT E-MAILED
27/12/2024
EXAMINERS AMENDMENT -WRITTEN
27/12/2024
NOTIFICATION OF FINAL REFUSAL EMAILED
16/12/2024
FINAL REFUSAL E-MAILED
16/12/2024
FINAL REFUSAL WRITTEN
16/12/2024
TEAS/EMAIL CORRESPONDENCE ENTERED
07/11/2024
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/11/2024
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/11/2024
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
09/10/2024
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
09/10/2024
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/07/2024
NON-FINAL ACTION E-MAILED
11/07/2024
NON-FINAL ACTION WRITTEN
11/07/2024
TEAS/EMAIL CORRESPONDENCE ENTERED
11/06/2024
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/06/2024
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/06/2024
TEAS CHANGE OF CORRESPONDENCE RECEIVED
31/05/2024
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
31/05/2024
TEAS CHANGE OF OWNER ADDRESS RECEIVED
31/05/2024
CORRESPONDENCE E-MAILED
27/03/2024
NON-FINAL ACTION WRITTEN
27/03/2024
TEAS CHANGE OF CORRESPONDENCE RECEIVED
27/03/2024
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
27/03/2024
TEAS CHANGE OF OWNER ADDRESS RECEIVED
27/03/2024
ASSIGNED TO EXAMINER
20/03/2024
NOTICE OF DESIGN SEARCH CODE E-MAILED
11/08/2023
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/08/2023
NEW APPLICATION ENTERED
15/07/2023
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.